Visual function in children with merosin-deficient and merosin-positive congenital muscular dystrophy

E Mercuri1, S Anker, J Philpot

  • 1Department of Paediatrics, Royal Postgraduate Medical School, University College, London, United Kingdom.

Pediatric Neurology
|July 3, 1998
PubMed

Insights

Children with congenital muscular dystrophy (CMD) show normal clinical visual function, even with white matter changes. However, visual evoked potentials may be abnormal in merosin-deficient CMD, indicating potential neurophysiological changes.

Area of Science:

  • Neurology
  • Ophthalmology
  • Genetics

Background:

  • Congenital muscular dystrophy (CMD) is a group of inherited neuromuscular disorders.
  • Visual impairments are sometimes associated with certain subtypes of CMD.
  • The relationship between clinical visual function, merosin status, and neuroimaging in classical CMD requires further elucidation.

Purpose of the Study:

  • To investigate visual function abnormalities in children diagnosed with classical congenital muscular dystrophy.
  • To determine if visual function deficits correlate with merosin status or magnetic resonance imaging (MRI) findings.
  • To compare clinical visual assessments with neurophysiological measures like visual evoked potentials (VEPs).

Main Methods:

  • Twenty children (aged 5-17 years) with classical CMD underwent assessments of visual acuity, stereopsis, and visual fields.
  • Merosin status and brain MRI findings were analyzed.
  • Visual evoked potential (VEP) data were obtained for 14 participants.

Main Results:

  • All 20 children exhibited normal clinical visual function across all tested parameters, irrespective of merosin status or MRI results.
  • VEPs were normal in merosin-positive CMD but abnormal in merosin-deficient CMD.
  • Despite white matter changes in the occipital lobes on MRI and abnormal VEPs, clinical visual function remained normal in merosin-deficient CMD.

Conclusions:

  • Classical congenital muscular dystrophy does not present with clinical visual function abnormalities.
  • Merosin deficiency in CMD may be associated with subclinical neurophysiological visual pathway changes, as indicated by VEPs.
  • Further research is necessary to understand the nature of white matter changes and the discrepancy between clinical and neurophysiological findings in merosin-deficient CMD.